Shenglin Ma
- Molecular Biology top 10%
- Cancer Research top 5%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Biomedical Engineering
- Topics
- Lung Cancer Treatments and Mutations (25 papers)Lung Cancer Research Studies (16 papers)MicroRNA in disease regulation (12 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Shenglin Ma
87 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 113
- Molecular Biology 818
- Cancer Research 518
- Oncology 498
- Pulmonary and Respiratory Medicine 459
- Biomedical Engineering 170
Countries citing papers authored by Shenglin Ma
This map shows the geographic impact of Shenglin Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglin Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglin Ma more than expected).
Fields of papers citing papers by Shenglin Ma
This network shows the impact of papers produced by Shenglin Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglin Ma. The network helps show where Shenglin Ma may publish in the future.
Co-authorship network of co-authors of Shenglin Ma
This figure shows the co-authorship network connecting the top 25 collaborators of Shenglin Ma. A scholar is included among the top collaborators of Shenglin Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenglin Ma. Shenglin Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 9 | |
| 4 | 25 | |
| 5 | 6 | |
| 6 | 5 | |
| 7 | 1 | |
| 8 | 13 | |
| 9 | 12 | |
| 10 | 2 | |
| 11 | 6 | |
| 12 | 9 | |
| 13 | 15 | |
| 14 | 43 | |
| 15 | 4 | |
| 16 | 12 | |
| 17 | 13 | |
| 18 | 31 | |
| 19 | 12 | |
| 20 | 6 |
About Shenglin Ma
Shenglin Ma is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 92 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (25 papers), Lung Cancer Research Studies (16 papers) and MicroRNA in disease regulation (12 papers). The work is most often cited by research in Cancer Research (518 citations), Oncology (498 citations) and Pulmonary and Respiratory Medicine (459 citations). Shenglin Ma has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Shirong Zhang, Lucheng Zhu, Dan Su, Kan Wu, Bing Xia, Jianguo Feng, Hongfang Zhang, Yanyan Zhao, Hong Jiang and Hao Jiang. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.